First Light Asset Management LLC Purchases New Shares in Humana Inc. (NYSE:HUM)

First Light Asset Management LLC acquired a new stake in Humana Inc. (NYSE:HUMFree Report) in the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund acquired 16,139 shares of the insurance provider’s stock, valued at approximately $6,030,000.

Other large investors have also modified their holdings of the company. Mendota Financial Group LLC boosted its position in Humana by 9.2% during the second quarter. Mendota Financial Group LLC now owns 319 shares of the insurance provider’s stock worth $119,000 after purchasing an additional 27 shares in the last quarter. Aurora Investment Counsel lifted its position in shares of Humana by 1.3% during the 4th quarter. Aurora Investment Counsel now owns 2,273 shares of the insurance provider’s stock valued at $1,155,000 after buying an additional 29 shares in the last quarter. Capital Advisors Ltd. LLC grew its stake in Humana by 17.0% in the 2nd quarter. Capital Advisors Ltd. LLC now owns 213 shares of the insurance provider’s stock valued at $80,000 after acquiring an additional 31 shares during the period. EP Wealth Advisors LLC increased its holdings in Humana by 1.6% in the 4th quarter. EP Wealth Advisors LLC now owns 2,294 shares of the insurance provider’s stock worth $1,050,000 after acquiring an additional 37 shares in the last quarter. Finally, CarsonAllaria Wealth Management Ltd. increased its holdings in Humana by 111.4% in the 2nd quarter. CarsonAllaria Wealth Management Ltd. now owns 74 shares of the insurance provider’s stock worth $28,000 after acquiring an additional 39 shares in the last quarter. Institutional investors and hedge funds own 92.38% of the company’s stock.

Wall Street Analysts Forecast Growth

Several analysts have recently issued reports on HUM shares. Baird R W upgraded shares of Humana to a “hold” rating in a research report on Thursday, May 30th. Piper Sandler initiated coverage on shares of Humana in a research report on Wednesday, June 26th. They set an “overweight” rating and a $392.00 price target on the stock. JPMorgan Chase & Co. increased their price objective on shares of Humana from $332.00 to $396.00 and gave the company a “neutral” rating in a report on Wednesday, August 21st. Deutsche Bank Aktiengesellschaft boosted their target price on Humana from $341.00 to $349.00 and gave the stock a “hold” rating in a report on Friday, August 2nd. Finally, Royal Bank of Canada increased their price target on Humana from $385.00 to $400.00 and gave the company an “outperform” rating in a report on Thursday, September 5th. Thirteen research analysts have rated the stock with a hold rating and nine have issued a buy rating to the company’s stock. According to MarketBeat.com, the company presently has a consensus rating of “Hold” and an average price target of $398.70.

View Our Latest Report on HUM

Humana Price Performance

Humana stock opened at $312.74 on Tuesday. The company’s 50 day simple moving average is $356.28 and its 200-day simple moving average is $345.36. The company has a debt-to-equity ratio of 0.70, a quick ratio of 1.66 and a current ratio of 1.66. Humana Inc. has a 1 year low of $298.61 and a 1 year high of $530.54. The company has a market capitalization of $37.69 billion, a price-to-earnings ratio of 19.47, a price-to-earnings-growth ratio of 2.56 and a beta of 0.50.

Humana (NYSE:HUMGet Free Report) last announced its earnings results on Wednesday, July 31st. The insurance provider reported $6.96 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $5.89 by $1.07. Humana had a return on equity of 16.12% and a net margin of 1.53%. The company had revenue of $29.54 billion for the quarter, compared to analyst estimates of $28.52 billion. During the same quarter in the previous year, the company earned $8.94 earnings per share. The firm’s quarterly revenue was up 10.4% compared to the same quarter last year. As a group, equities research analysts expect that Humana Inc. will post 16 earnings per share for the current year.

Humana Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, October 25th. Investors of record on Monday, September 30th will be paid a dividend of $0.885 per share. This represents a $3.54 annualized dividend and a yield of 1.13%. The ex-dividend date of this dividend is Monday, September 30th. Humana’s payout ratio is 22.04%.

Humana Profile

(Free Report)

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.

See Also

Want to see what other hedge funds are holding HUM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Humana Inc. (NYSE:HUMFree Report).

Institutional Ownership by Quarter for Humana (NYSE:HUM)

Receive News & Ratings for Humana Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana and related companies with MarketBeat.com's FREE daily email newsletter.